Entry Point Capital, LLC Trans Medics Group, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 99 shares of TMDX stock, worth $14,990. This represents 0.02% of its overall portfolio holdings.
Number of Shares
99Holding current value
$14,990% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$401 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$383 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$225 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$206 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$173 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.82B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...